Introduction
Fewer than 10% of all healthcare systems in the United States use significant computerisation, despite the fact that healthcare delivery through integrated computer systems yields reduced medical errors and lowered medical costs. [1] [2] [3] [4] [5] While many have attempted to implement healthcare information technology solutions, costly failure has been the rule, not the exception. 6, 7 Substantial literature exists regarding the barriers to the implementation of electronic health records/electronic medical records (EHR/EMR) in medicine. 1, 3, [8] [9] [10] [11] [12] [13] [14] Identified barriers include lack of ability to exchange data, high cost, lack of standardisation and multiple organisational issues. Despite the identification of these barriers and attempts at solutions, such as medical record data exchange standards like HL7, the proliferation of these technologies in medicine has not proceeded to the extent that it has in other industries. 15 Even the 'successes' have major ethical, training, disaster preparedness and sustainability problems. 12, 14, 16, 17 Under the present circumstances, a patient is likely to have a longer life than the software on which their medical record is stored, making access to these vital data difficult or impossible. 18 A systematic examination of reasons for the failure of widespread use of clinical computing software in medicine is an important step in improving the penetration of these vital technologies. 2 We examined American Academy of Family Physicians (AAFP) member survey data to achieve the following goals:
to characterise users and non-users of EHRs/EMRs to examine the number of unique EHR/EMR software packages in use among AAFP members to identify potential barriers to their use to suggest possible solutions to identified barriers.
Our hypothesis is that the lack of standard software is a major barrier to proliferation of EHR/EMR software. Proliferation of standard EMR software is an essential condition for healthcare delivery through integrated computer systems. 2 
Methods
The AAFP collected member survey data in January 2003 to measure interest in an AAFP-sponsored EHR/EMR service. The study population consisted of active members of the AAFP (n=55 400) with email addresses (n=35 554; 64%). We performed a secondary analysis of these data using an electronic spreadsheet and SAS™ statistical software. The survey consisted of seven questions on the following topics: current use of EHR/EMR, name of currently used EHR/EMR, gender, age, region, reasonable amount to pay per month for constant EHR/EMR service, and reasons why EHR/EMR software has not been purchased.
Statistical analysis was done on the demographic data in order to identify possible trends in the use and non-use of EHR/EMR, interest in purchasing EHR/EMR software and the amount willing to pay per month for constant EHR/EMR service. Chisquare (c 2 ) tests and t-tests were used to examine differences between the two groups for discrete-valued and continuous-valued variables, respectively. We performed univariate analyses using the c 2 test to examine differences in interest (yes/no) across region, age and gender. We performed univariate analyses using the t-test to examine the differences in amount willing to pay across region, age and gender. Finally, we utilised two regression models to analyse variance in (1) interest in an EHR/EMR and (2) amount willing to pay. To examine the variance explained by region, age and gender on interest (yes/no) in EHR/EMR, a logistic regression was performed. A linear regression was done to examine the variance explained by age, region and gender on the amount willing to pay for EHR/EMR.
Examination of the extent of unique software systems across reported EHR/EMR software was done by sorting the EHR/EMR programs in our dataset by name and then counting the number of unique EHR/ EMR programs listed, as well as the number of users for each unique EHR/EMR program. Uniformity of the data was achieved by changing inexact but obvious matches, such as misspellings or a company name versus the name of the product the company sells. All locally developed software was categorised as 'in-house' . In-house software was counted as a single vendor or group, despite the high likelihood of nonstandardisation. This assumption would tend to underestimate the effect we were assessing. Standardisation is an important contributor to the ability of these systems to be used. 19 
Results
Of the AAFP members with email addresses, 5517 responded to the survey, producing a response rate of 15.5%. The average age of respondents was 46 years (SD ± 9 years, range 24-80), non-respondents' average age was 44.6 (SD ± 9.5 years, range 25-91), and 4348 (78.8%) of respondents were men versus 68.3% of non-respondents. The average age of an EHR/EMR user was 45 (SD ± 8, range 26-80) and 1044 (80.5%) were men. Of those responding, 1297 (23.5% of respondents) reported use of an EHR/EMR, 4211 (76.3% of respondents, 7.6% of all AAFP members) reported no use of an EHR/EMR, and 9 (0.2%) made no response.
No difference existed in current use of EHR/ EMR across demographic groups. Table 1 displays the differences in current use, interest and amount willing to pay per month for EHR/EMR service across gender, population density (urban/rural), region and age group.
Males and those in younger age groups (82.0%, P=0.003 and 83.7%, P=0.01, respectively) had increased interest in purchasing EHR/EMR. There was little difference in interest for urban versus rural groups (80.6% vs 82.7%, P=0.29). Subjects under 40 years old reported the highest rate of interest in EHR/EMR use at 83.7%, with those aged 40-65 reporting 80.4% interest, and those over 65 (n=114) reporting 75.3% interest (P=0.01). Regional differences existed, indicating more interest in the South (P=0.004). Within the logistic regression model, we examined odds of use of EHR/EMR, controlling for region, age and gender. After adjustment for age and gender, those in the South were significantly more likely to be interested in EHR (OR: 1.4, CI: 1.2-1.7, P 0.0001). Each ten-year increase in age resulted in a significant decrease in interest in EHR/EMR (OR: 0.8, CI: 0.7-0.9, P 0.0001), after being adjusted for gender and region within the logistic regression. After adjusting for age and region, females were significantly less likely to be interested in EHR/EMR (OR: 0.7, CI: 0.6-0.9, P 0.0001).
The average member would be willing to pay $152 per month (SD ± $414, range 0-20 000) for an AAFPsponsored EHR/EMR service. Males would be willing to pay on average $156/month versus $126/month for females (P 0.003). There was no difference among age groups for the amount physicians would be willing to pay (P=0.52). The average clinician in the Northeast region would be willing to pay $127; the West, $145; the South, $146 and the Midwest, $182 (P 0.04). Linear regression examining the variance in the amount those surveyed were willing to pay by region, age and gender showed no significance for any of the variables. Table 2 shows the reasons respondents gave for not purchasing EHR/EMR software. Cost concerns (n=2548, 60.5%), work slow-down (n=2282, 54.2%), concern that the company may go out of business (n=1629, 38.7%) and security/privacy issues (n=998, 23.7%) were the most common reasons given. More than one answer could be given, resulting in percentages Table 3 shows that there were four medical software vendors that accounted for the four most frequently reported installations -Centricity/Logician/ Medicalogic/GE, Physician Micro Systems/Practice Partner, Epic/EpicCare/Epic Systems and Docs, Inc/Soapware (n=148, 138, 108 and 90, respectively) -accounting for 37% of the total number of users of EHR/EMR software in this sample and 0.9% of all 55 400 AAFP members. The fifth largest group reported was 'unknown' (n=62). The sixth largest group consisted of those who used locally developed, 'in-house' software (n=60). The seventh largest category (n=56), 'Government' , used CHCS/VistA software, which is available in the public domain. The remainder of the EHR/EMR software users were placed in an arbitrary 'Other' category of EHR/EMR users and consisted of groups with less than 56 users (n=635). The largest group of EHR/EMR users using the same software in this sample was 2.6% of the respondents. At least 264 different EHR/EMR programs were currently being used among the family physicians that responded to the survey, which averages to 1297/264 = 4.9 or 0.4% of respondents who use the same EHR/ EMR.
Discussion
Our results show that among this small sample of AAFP members, there were a large (n=264) number of unique medical record software systems in use. We believe the likelihood is low that standardisation is occurring among these unique medical records 2 The demographic data revealed little difference in current use of EHR/EMR software by gender, population density, region or age group. This indicates a stable equilibrium of low usage across groups and the presence of an insurmountable barrier. Males and younger age groups seemed to be somewhat more interested in EHR/EMR software, perhaps due to greater exposure to computers among these populations. Our findings that those in the South had the most interest and that those in the North had the least interest confirmed the findings of Lenhart et al. 20 The $152 that the average AAFP member is willing to pay suggests the possibility that a transition from a proprietary licence-based industry to a service-oriented one could be viable. Males appeared to be willing to pay more for the software than females. Concerns about decreased productivity, that partners won't accept the software, about cost and that the company selling the software may go out of business are likely to be legitimate reflections of the commonplace expensive failures that medicine has experienced. 6, 7 The low percentage (8.3%) of clinicians reporting concern about inadequate typing skills is similar to the results of Rind and Safran, who also found this to be much less of a problem than expected. 13 The strongest findings are that greater than 264 unique types of EHR/EMR software implementations are in current use among respondents, resulting in only 0.4% of respondents using the same software. The actual rate of unique software systems is likely to be much higher, based on the assumptions inherent in treating 'in-house' and 'unknown' software groups as only one unique EHR/EMR each. Our findings illustrate the magnitude of the problem and are consistent with previous studies that found standardisation to be a major barrier to proliferation. 14,21 Such widespread non-standardisation results in a great devaluation of existing implementations.
The devaluation due to non-standardisation can be measured through the application of Metcalfe's Law. Metcalfe's Law states that 'the value of a network grows as the square of its number of users'. 22 The definition of 'value' in this law is a broad one, and it can include but is not limited to the following: computing, economic, social, political and communication values. In short, to get the maximum value, one must connect with everyone else and be like everyone else. 23 A concrete example of the law is that a one-node network, such as a single telephone, has the power to communicate only with itself, and therefore has a utility of 1 2 or 1. A usable two-node telephone network has a much greater utility than just double that of a one-node network, when taking into consideration its possibilities for economic, social and political activity. It therefore has a power of 2 2 or 4, with each added user increasing power, going to 3 2 and so on. When a 'critical mass' of standard users is reached, the value increases dramatically as well. Adoption of the technology accelerates and becomes ubiquitous once that mass has been achieved. This has occurred in other industries, yet medicine remains one of the few in which this necessary change has not occurred. 15 If all 55 400 AAFP members were using standard software, the network would have an arbitrary value of 55 400 2 or 3 069 160 000. Currently, the largest group of users with the same software is only 148, yielding an actual network value of just 148 2 = 21 904.
A potential solution to the barriers of standardisation, cost and business failure, identified in our study is Free and Open Source Software (FOSS) EHR/ EMR. 24, 25 FOSS is not a particular piece of software; rather, it is a software engineering method or a software agreement that results in alternatives to proprietary software. 'Free' refers to the safeguarding of software freedoms, not price. 26 It is not free of costs associated with installation, maintenance, support and training. 27 FOSS software is characterised by licences which guarantee access rights to program software, such as rights to 'run, copy, distribute, study, change and improve the software'. 26 One of the most highly regarded free licences is called the GNU General Public License, or GNU GPL for short. 28 These rights are not guaranteed with proprietary software and in fact are rarely available for it. Our data show that proprietary software dominates clinical computing in this sample.
Interconnectivity problems have been solved in the past using FOSS techniques. 29, 30 This is best demonstrated by the internet, which owes much of its universal nature to software developed in a free manner. [30] [31] [32] While FOSS is not a universal solution to interconnectivity (and other) problems, data exchange and standardisation problems are more easily solved using FOSS licences since no technical information can be hidden. 33 FOSS software can be incorporated without charge into a different product if it adheres to the terms of the licence. Permission to incorporate parts of FOSS software in whole or in part is explicitly granted in advance by the licence. The only real barriers to standardisation are technical, but not legal or political. FOSS may be effective in addressing the identified concerns of clinicians found in Table 2 of the survey, particularly those of cost and companies going out of business. FOSS systems can remove the cost and necessity of duplicate engineering, as well as removing disincentives to standardisation of both data and user interface. 31 Furthermore, the ability to test standardisation among multiple systems does not require purchasing each unique product. Currently, the likelihood that a vendor has the financial and technical means of buying all or even some proprietary competitors' products to do standardisation testing is exceedingly low, given the high cost of EHR/EMR software. 34 One study has shown that the FOSS-based Veterans Administration physician order entry system was preferred over a proprietary one. 35 The AAFP is actively developing a software service using FOSS techniques.
Our analysis has some limitations. First, the overall response rate of the survey was only 15.5%, which was lower than the 25-32% rates published in other online survey studies. 36 This may have biased our results by the exclusion of significant populations of EHR/EMR users. Second, self-selection bias may have occurred in the form of (a) having an email address, (b) responding to the survey and (c) being a member of AAFP. However, we believe that because those with the greatest interest in this topic are the most likely to respond, our findings are an underestimate of the true extent of the problem of non-standardisation of EHR/ EMR software. Third, our age findings may be biased due to the smaller number of respondents over the age of 65. Fourth, our assumption of standardisation among unique EHR/EMR may be flawed. Alternatively, it may also be true that 'standard' software cannot exchange records with itself easily. Despite the desirability and economic benefits of an integrated clinical software infrastructure, the near-term prospects for widespread use of standard EHR/EMR software appear poor. This is due to the devaluation of EHR/ EMR software through hundreds of unique systems. Fundamental change through the use of EHR/EMR software is widely recognised as necessary, but a specific mechanism for such change is lacking. Free and Open Source Software shows promise as a means to achieving the true potential of EMR software in improving health care.
